Application Analysis of (124)I-PPMN for Enhanced Retention in Tumors of Prostate Cancer Xenograft Mice

BACKGROUND: In recent years, nuclear medicine imaging and therapy for prostate cancer have radically changed through the introduction of radiolabeled prostate-specific membrane antigen (PSMA)-binding peptides. However, these small molecular probes have some inherent limitations, including high nephr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Lei, Wen, Li, Meng, Xiangxi, Zhou, Nina, Guo, Xiaoyi, Liu, Teli, Xu, Xiaoxia, Wang, Feng, Zhu, Hua, Yang, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612089/
https://www.ncbi.nlm.nih.gov/pubmed/34848955
http://dx.doi.org/10.2147/IJN.S330237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612089/
https://www.ncbi.nlm.nih.gov/pubmed/34848955
http://dx.doi.org/10.2147/IJN.S330237

Ejemplares similares